Centre to roll out biometric-based registration under Poshan 2.0 from August 1
Speaking at a Ministry zonal meeting at Kevadia in the Narmada district, Ms. Devi said the adoption of digital tools, such as the face recognition system used under Saksham Anganwadi, would bring greater transparency, accountability, and governance to the programme.
Saksham Anganwadi and Poshan 2.0 is an integrated nutrition support initiative catering to children, adolescent girls, pregnant women, and lactating mothers.
The Union Budget for 2025-26 has allocated ₹4.49 lakh crore for this initiative, covering 273 schemes by 49 Ministries in a push towards gender-inclusive governance, the Minister said.
Digital tools for better governance
To enhance capacity-building, dedicated learning modules for Mission Saksham Anganwadi and Poshan 2.0 will be hosted on the iGOT Karmayogi platform for use by field functionaries nationwide, she added.
Ms. Devi urged States and Union Territories to strengthen their grievance redressal mechanisms, improve digital literacy among adolescent girls and young mothers, and ensure timely delivery of services through Anganwadis. She also proposed transforming the Poshan Helpline into an interactive platform for citizen engagement and service quality feedback.
Ms. Devi highlighted the Aadhaar-enabled Direct Benefit Transfers under the Pradhan Mantri Matru Vandana Yojana as a key transparency measure and encouraged all States and UTs to adopt the Mission Vatsalya portal for real-time data monitoring.
Participants at the zonal meeting included Minister of State Savitri Thakur, Ministers from the Gujarat, Madhya Pradesh, and Rajasthan governments, and senior officials from five western States. Discussions focused on convergence under Mission Shakti, Mission Vatsalya, and Poshan 2.0, with States showcasing best practices and innovations.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Wire
an hour ago
- The Wire
Antibiotics, Diabetes and BP Drugs, Vitamin Supplements Found to Be Not of Standard Quality in June
Health Banjot Kaur Issues that Union and state regulators detected during their monthly inspections include contamination and incorrect labelling. Representative image of tablet drugs. Photo: New Delhi: Batches of as many as 185 drugs were found to be not of standard quality (NSQ) by Union and state drug regulators during their monthly inspection in June. The results of their inspections were released on Friday (July 18). A drug is labelled NSQ if it does not meet the quality standards laid down in the Indian laws governing drugs. The Central Drugs Standard Control Organisation (CDSCO) found batches of 55 drugs NSQ, with batches of the remaining 130 being flagged by various state drug regulators. The CDSCO is India's drug regulator at the Union government level. This is not a one-off list. It is a monthly document that the CDSCO publishes. The exercise became regular about a year ago. 'As part of the continuous regulatory surveillance, drug samples are picked from sales/distribution point and analysed, and the list of spurious [NSQ] drugs are displayed on the CDSCO portal on a monthly basis,' the CDSCO said. The purpose of displaying the list is to make stakeholders aware about the NSQ batches identified in the market, it added. The drugs that the CDSCO and state regulators most commonly found to be NSQ were mainly antibiotics, vitamin and calcium supplements, and anti-hypertensives (used for controlling blood pressure) in oral and injectable forms. The companies mentioned in this article are not the only ones whose products were found to be NSQ. We have only considered companies that made either multiple batches of a given drug that were found sub-par, or those that have manufactured various drugs that were found sub-par. It must be mentioned here that the CDSCO's and the states' labs only test a certain batch(es) of a particular medicine. If one batch of any drug has been red-flagged, it does not necessarily mean that all its batches would be substandard. Common 'errors' One of the most serious risks associated with NSQ drugs is improper sterility. This means that the drug contains harmful microorganisms that can lead to infection in a patient's body after ingestion. This could potentially cause extremely serious complications in patients, like sepsis or even death due to acute infection. The other common problem that some drugs have is that they contain 'particulate matter' – particles that inadvertently enter the drug during the manufacturing process. These particles can contaminate the drug. A 'description' error is one in which a drug's physical appearance does not match its prescribed appearance as per regulation. For example, if a tablet is described in regulation as having a white colour but a patient finds it to be orange, the tablet would have a description error. Several medicines were reported as experiencing 'loss on drying'. This error reflects the lack of moisture in drugs, which may cause microbial growth in them, potentially causing infection if ingested. A drug is labelled as having assay errors when an ingredient in it is found in a quantity that is higher or lower than what is mentioned on its label. A higher amount would mean an overdose and a lower amount would result in an underdose – the latter would lead to a situation where a patient even after consuming the prescribed strength of a drug ends up ingesting a lower quantity of some ingredient. This can lead to their disease getting worse. 'Extractable volume' errors usually occur with vials. If the liquid that is to be extracted from a vial using a syringe is present in a quantity greater or lower than as labelled, this can again lead to an overdose or underdose of the drug given in injectable form. 'Dissolution' errors can adversely affect the absorption of a drug. What did the CDSCO find? Six drugs manufactured by Paksons Pharmaceuticals Private Limited were found to be NSQ. These include a dexamethasone sodium phosphate injection – an antibiotic; an ascorbic acid injection, used as a vitamin C supplement; an adrenaline bitartrate injection, used during cardiac arrest; an ondansetron injection, used for treating nausea caused by cancer medicines; and a gentamicin injection, used for treating bacterial injections. The company's diclofenac sodium injection, used as a pain killer, had extractable volume issues in its vials. Four batches of Phaex Polymers Private Limited's colestyramine (used to treat high cholesterol) and three batches of its sodium polystyrene sulfonate (for regulating potassium levels) reported 'loss of drying' mistakes. Zee Laboratories' tranexamic acid injection, used for controlling excessive loss of blood during surgery in patients suffering from hemophilia, reported assay problems. On the other hand, its glipizide & metformin tablets, used for treating high blood sugar, had a description error. Two batches of Overseas Health Care Pvt Ltd's calcium aspartate, calcium orotate, calcitriol minerals and vitamin tablets, which are used to supplement calcium and micronutrients like zinc and vitamins to treat deficiencies, had compromised assays for almost all of their ingredients. Martin & Brown BioSciences Pvt Ltd's calcium gluconate injection had particulate matter and description errors along with extractable volume issues. Three batches of its rabeprazole sodium injection – used to treat acid reflux – also had particulate matter and assay problems. Two batches of E.G. Pharmaceuticals' vitamin C injection and vitamin B12, folic acid and niacinamide injection had particulate matter and description errors. Two batches of Healers Lab's telmisartan tablets (used to manage blood pressure) had dissolution issues. What did state drug regulators find? State drug regulators too found serious errors in some drugs. Five batches of Puniska Injectables's sodium chloride injection had serious sterility problems. These injections have multiple purposes. They are primarily given in cases of dehydration to restore electrolytes (sodium and chlorine). Similarly, Paschim Banga's dextrose injection, which is used to normalise blood sugar levels, and its sodium chloride injection, had sterility issues. Thirteen batches of Martin & Brown BioSciences' calcium and vitamin D3 tablets had description errors. Vivek Pharmachem's paracetamol and ciprofloxacin hydrochloride tablets had description and dissolution issues respectively. Safe Care Life Sciences's mecobalamin 2,500 mg injection, which is used for vitamin B12 supplementation, had 2.38 mg per ml of mecobalamin against the labelled claim of 2,500 mg per ml in its vial. Two batches of Oscar Remedies's ciprofloxacin & dexamethasone eye/ear drops had 943.33% more ciprofloxacin than the labelled amount. The full lists of NSQ drugs made by the CDSCO and state regulators can be found here and here respectively. The Wire is now on WhatsApp. Follow our channel for sharp analysis and opinions on the latest developments.
Time of India
4 hours ago
- Time of India
Varanasi to host Youth Spiritual Summit against drug abuse
Varanasi: The Central govt will organise a two-day 'Youth Spiritual Summit' on the theme 'Drug-Free Youth for a Developed India' in Varanasi on Saturday and Sunday. "Over 500 young representatives from 100 spiritual and socio-cultural organisations across the country will take part in the summit organised by Ministry of Youth Affairs and Sports. It aims to promote the collective national resolve inherent in India's spiritual heritage," a PIB release said. Dignitaries, including the Himachal Pradesh governor Shiv Pratap Shukla, Union ministers Mansukh Mandaviya, Gajendra Singh Shekhawat, Virendra Kumar, Nityanand Rai, Raksha Nikhil Khadse and UP ministers Girish Yadav, Asim Arun and Nitin Agarwal, will also attend the event. The summit is part of the ministry's broader mission to initiate a value-based, youth-led mass movement against drug abuse. Designed as an intensive experience, the summit will combine introspective dialogue with cultural and spiritual engagement. Four plenary sessions will discuss key topics: understanding the psychological and social impacts of addiction, dismantling drug supply and trafficking networks, effective grassroots campaigns and communication strategies, and drafting a blueprint for building a drug-free India. Alongside these discussions, platforms for youth ideas and innovations will be provided through whiteboard forums, expert keynote speeches and workshops. The summit will conclude with the release of the 'Kashi Declaration' that will reflect the collective vision and commitment of youth and spiritual leaders and present a comprehensive action plan for building a drug-free India. It will serve as a guiding charter for policymakers, civil society organisations, and youth networks working in the field of de-addiction and rehabilitation. In collaboration with the My Bharat platform, this summit will also launch a national mass movement against drugs, with My Bharat volunteers and affiliated youth clubs leading awareness campaigns, pledge drives and grassroots outreach activities in villages, towns, and cities across the country.
The Hindu
5 hours ago
- The Hindu
Mosquito control workers of Chennai Corporation protest seeking permanent appointment
Malaria prevention workers staged a protest in Chennai on Friday, demanding permanent employment under the National Urban Livelihoods Mission (NULM) scheme. On Friday, around 200 workers assembled near Egmore for a silent protest. According to a press release issued by the Union, affiliated with the All India Trade Union Congress (AITUC), these workers have been engaged in mosquito control operations across all Greater Chennai Corporation (GCC) zones for the past 13 years. The organisation submitted a petition demanding permanency for all mosquito control workers engaged under the scheme. Their duties included spraying oil in stagnant water, fogging, source reduction, conducting inspections, public awareness drives and controlling dengue, malaria, tuberculosis, and other communicable diseases. N. Beulah John Selvaraj, President of the Union, who led the protest, said the demand for permanency has been long pending and the protest will continue till GCC responds to the requests.
